ID: ALA5178037

Max Phase: Preclinical

Molecular Formula: C11H11NO2S

Molecular Weight: 221.28

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(c1)NC(=CC(C)=O)S2

Standard InChI:  InChI=1S/C11H11NO2S/c1-7(13)5-11-12-9-6-8(14-2)3-4-10(9)15-11/h3-6,12H,1-2H3

Standard InChI Key:  XYGZDCKYTOQIDI-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 221.28Molecular Weight (Monoisotopic): 221.0510AlogP: 2.64#Rotatable Bonds: 2
Polar Surface Area: 38.33Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.52CX Basic pKa: CX LogP: 2.13CX LogD: 2.13
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.78Np Likeness Score: -0.29

References

1. Carrillo García C, Becker C, Forster M, Lohmann S, Freitag P, Laufer S, Sievers S, Fleischmann BK, Hesse M, Schade D..  (2022)  High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation.,  65  (2.0): [PMID:34818008] [10.1021/acs.jmedchem.1c01173]

Source